Network origin in Anne M. LeDoux first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anne M. LeDoux via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | General Counsel Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing President Corporate Officer/Principal | |
| MCKESSON CORPORATION | Medical Distributors | Chief Executive Officer | |
| GEN DIGITAL INC. | Packaged Software | Director/Board Member | |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Private Equity Investor Private Equity Investor | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
Reaction Biology Corp.
 Reaction Biology Corp. Miscellaneous Commercial ServicesCommercial Services Reaction Biology Corp. specializes in kinase and epigenetic HTS and profiling services. It offers radiolabeled biochemical assays available for multiple enzyme classes including: Kinase Assays, HMT Assays, and HDAC Assays. Its products include Methyltransferase, IDH proteins, Apoptosis, DNA Demethylation, Apoptosis and NQOs. The company was founded by Scott L. Diamond in 2001 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member President | |
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Delta Opportunity Fund LLC | Corporate Officer/Principal | ||
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
KQED, Inc.
 KQED, Inc. BroadcastingConsumer Services KQED, Inc. operates television and radio broadcasting stations. The firm provides non-commercial programming to San Francisco audiences through Public Television 9, Digital Television 30, Public Radio 88.5FM & 89.3FM, KQED Education Network & dot org. The company was founded in 1954 and is headquartered in San Francisco, CA. | Broadcasting | Director/Board Member | |
Mercy Corps
 Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Services to the Health Industry | Director/Board Member | |
| The University of Chicago | College/University | Graduate Degree Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of California, Davis | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
Ortho Biotech Products LP
 Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Ortho Biotech Products LP provides innovative products and services which are designed to enhance the lives of individuals with serious chronic illnesses. The company's products include PROCRIT, DOXIL and LEUSTATIN. Ortho Biotech Products was founded in 1990 and is headquartered in Bridgewater, NJ | Pharmaceuticals: Major | Sales & Marketing President | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Riecken Foundation | President Director/Board Member | ||
San Francisco Museum of Modern Art
 San Francisco Museum of Modern Art Other Consumer ServicesConsumer Services San Francisco Museum of Modern Art provides exhibitions, education, publications, collections, and related public programs. The company was founded by Grace McCann on January 18, 1935 and is headquartered in San Francisco, CA. | Other Consumer Services | Director/Board Member | |
Lemo USA, Inc.
 Lemo USA, Inc. Electronic ComponentsElectronic Technology Lemo USA, Inc. designs and manufactures custom connectors. It offers low voltage connectors, plastic and miniature connectors, high pressure and high voltage connectors, media converter, and cable assemblies. The company is headquartered in Rohnert Park, CA. | Electronic Components | Director/Board Member | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member President | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Graduate Degree | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member | |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
| APTINYX | Pharmaceuticals: Major | Director/Board Member | |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology CuraSen Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda in 2018 and is headquartered in San Mateo, CA. | Biotechnology | Director/Board Member | |
Pequot Capital Corp.
 Pequot Capital Corp. Investment ManagersFinance Pequot Capital Corp. provides investment advisory services. | Investment Managers | Private Equity Investor | |
| VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Opna Immuno-Oncology SA
 Opna Immuno-Oncology SA BiotechnologyHealth Technology Opna Immuno-Oncology SA is a Swiss biotechnology company that focuses on researching and developing biotechnology products. The private company is based in Saint-Sulpice, Switzerland. | Biotechnology | Director/Board Member | |
Endeavor BioMedicines, Inc
 Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Endeavor BioMedicines, Inc is a clinical stage company located in Solana Beach, CA, that develops novel therapies for fibrosis and oncology. The company's lead program, env-101, is a hedgehog signalling inhibitor currently in phase 2 studies treating IPF, a progressive interstitial lung disease that causes inflammation and scarring in the lung. The company's second program is a HER3-targeted ADC that will begin clinical development in 2024 for the treatment of multiple solid tumors. The company's mission is to develop transformative medicines by targeting the underlying genetic and cellular causes of disease with best in class agents. Endeavor is partnered with XCures and is currently looking at the LOF mutation. Regardless of eligibility for the Endeavor trial, XCures will still send a list of other treatment options that could work for the cancer mutation. The company was founded by Miguel A. de los Ríos and John Hood, with John Hood serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| United States | 47 |
| Ireland | 3 |
| United Kingdom | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 3 |
Operational
| Director/Board Member | 212 |
| Corporate Officer/Principal | 66 |
| Independent Dir/Board Member | 65 |
| Chairman | 29 |
| Director of Finance/CFO | 26 |
Most connected contacts
| Insiders | |
|---|---|
| Daniel Bradbury | 45 |
| Patrick Enright | 41 |
| John Johnson | 40 |
| Richard Kollender | 30 |
| Edward Penhoet | 29 |
| David Singer | 28 |
| Joseph Turner | 22 |
| David Mahoney | 21 |
| Caroline Loewy | 17 |
| Bruce Williams | 14 |
| James A. Harper | 12 |
| Fred Kurland | 11 |
| Daniel Swisher | 10 |
| Robert L. Roe | 10 |
| Steven Lo | 9 |
- Stock Market
- Insiders
- Anne M. LeDoux
- Company connections
